ClinicalTrials.Veeva

Menu

Prophylactic Laser Treatment of Drusen Maculopathy

U

University Hospital, Linkoeping

Status

Completed

Conditions

Age-related Macular Degeneration

Treatments

Procedure: laser treatment

Study type

Interventional

Funder types

Other

Identifiers

NCT00348543
Dnr 97346

Details and patient eligibility

About

To study the effect of mild laser treatment on the incidence of exudative complications in soft drusen maculopathy. We hypothesise that mild laser treatment causing a proliferation of the retinal pigment epithelium and enhancing the capacity of clearing drusen material from Bruch's membrane.

Sex

All

Ages

55+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • > 55 years of age,
  • Soft drusen maculopathy,
  • VA 0.8-1.0

Exclusion criteria

  • VA <0.8,
  • Pigment clumps,
  • PED,
  • CNV,
  • Atrophy,
  • Haemorrhage,
  • Diabetes retinopathy,
  • Sign cataract,
  • Glaucoma

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems